Media coverage about VWR (NASDAQ:VWR) has trended somewhat positive recently, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. VWR earned a news sentiment score of 0.22 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 46.6329133402896 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Here are some of the news stories that may have effected Accern’s rankings:
- BioHealth Innovation Appoints Three New Board Members (bizjournals.com)
- Job fair set in Visalia Industrial Park (centralvalleybusinesstimes.com)
- Ultra-Low Temperature Freezer Market Able To Reach USD 701.4 million With CAGR of 2.7%. In 2022 (medgadget.com)
- VWR Corp (VWR) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com)
Shares of VWR (VWR) remained flat at $$33.25 during midday trading on Thursday. 2,797,900 shares of the company traded hands, compared to its average volume of 983,321. VWR has a twelve month low of $24.42 and a twelve month high of $37.25. The firm has a market cap of $4,380.00 and a P/E ratio of 17.32. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.25 and a quick ratio of 0.79.
VWR (NASDAQ:VWR) last announced its earnings results on Tuesday, November 7th. The medical research company reported $0.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.46 by $0.08. VWR had a net margin of 4.11% and a return on equity of 11.79%. The business had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.16 billion. During the same quarter last year, the firm earned $0.44 earnings per share. The business’s revenue for the quarter was up 5.2% on a year-over-year basis. equities research analysts anticipate that VWR will post 1.85 earnings per share for the current year.
A number of research firms recently commented on VWR. Zacks Investment Research cut VWR from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. ValuEngine upgraded shares of VWR from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. Finally, BidaskClub upgraded shares of VWR from a “strong sell” rating to a “sell” rating in a report on Saturday, September 23rd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $31.67.
WARNING: This story was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.truebluetribune.com/2017/12/14/vwr-vwr-earning-somewhat-favorable-news-coverage-study-shows.html.
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
Receive News & Ratings for VWR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR and related companies with MarketBeat.com's FREE daily email newsletter.